These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3056754)

  • 1. The prognostic value of quantitative analysis in the endometrial carcinoma.
    Aalto ML
    Eur J Obstet Gynecol Reprod Biol; 1988 Oct; 29(2):159-65. PubMed ID: 3056754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosquamous carcinoma of the endometrium. An entity with an inherent poor prognosis?
    Salazar OM; DePapp EW; Bonfiglio TA; Feldstein ML; Rubin P; Rudolph JH
    Cancer; 1977 Jul; 40(1):119-30. PubMed ID: 880545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoacanthoma and mixed adenosquamous carcinoma of the endometrium. A clinicopathologic study.
    Silverberg SG; Bolin MG; DeGiorgi LS
    Cancer; 1972 Nov; 30(5):1307-14. PubMed ID: 5083064
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of stage II endometrial carcinoma.
    Boothby RA; Carlson JA; Neiman W; Rubin MM; Morgan MA; Schultz D; Mikuta JJ
    Gynecol Oncol; 1989 May; 33(2):204-8. PubMed ID: 2495242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of histological variants of adenosquamous carcinoma of the corpus uteri].
    Smirnov OA
    Vopr Onkol; 1984; 30(3):32-7. PubMed ID: 6710946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histology and prognosis of endometrial carcinoma].
    Sakamoto A; Hirai Y; Yamauchi K; Kitagawa T; Sugano H; Masubuchi K; Hasumi K
    Gan No Rinsho; 1987 Dec; 33(15):1897-900. PubMed ID: 3430742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
    Demopoulos RI; Dubin N; Noumoff J; Blaustein A; Sommers GM
    Obstet Gynecol; 1986 Aug; 68(2):245-50. PubMed ID: 3737041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma.
    Zaino RJ; Kurman RJ
    Semin Diagn Pathol; 1988 May; 5(2):154-71. PubMed ID: 3041509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic features of sarcomas and mixed tumors of the endometrium.
    Peters WA; Kumar NB; Fleming WP; Morley GW
    Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of histologic grade in stage II endometrial carcinoma.
    Goplerud DR; Belgrad R
    Surg Gynecol Obstet; 1979 Mar; 148(3):406-8. PubMed ID: 419444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial carcinoma: stage I. A retrospective analysis of 262 patients.
    De Palo G; Kenda R; Andreola S; Luciani L; Musumeci R; Rilke F
    Obstet Gynecol; 1982 Aug; 60(2):225-31. PubMed ID: 7155485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoepidermoid and adenosquamous carcinoma of the uterus. A clinicopathologic study of 118 cases.
    Julian CG; Daikoku NH; Gillespie A
    Am J Obstet Gynecol; 1977 May; 128(1):106-16. PubMed ID: 851156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial adenocarcinoma: clinical outcome in 881 patients and analysis of 146 patients whose deaths were due to endometrial cancer.
    Tiitinen A; Forss M; Aho I; Vesterinen E; Nieminen U
    Gynecol Oncol; 1986 Sep; 25(1):11-9. PubMed ID: 3732910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of adenomyosis in endometrial carcinoma.
    Hall JB; Young RH; Nelson JH
    Gynecol Oncol; 1984 Jan; 17(1):32-40. PubMed ID: 6693051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
    Creasman WT; Soper JT; McCarty KS; McCarty KS; Hinshaw W; Clarke-Pearson DL
    Am J Obstet Gynecol; 1985 Apr; 151(7):922-32. PubMed ID: 3985057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups.
    Mittal KR; Schwartz PE; Barwick KW
    Cancer; 1988 Feb; 61(3):538-45. PubMed ID: 3338021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatment procedure for stage I endometrial adenocarcinoma.
    Wolff JP; Pejovic MH; Michel G; Gerbaulet A; Prade M; George M
    Gynecol Oncol; 1986 Jan; 23(1):51-8. PubMed ID: 3943752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements.
    Vesterinen E; Forss M; Nieminen U
    Gynecol Oncol; 1989 Apr; 33(1):49-53. PubMed ID: 2703167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of treatment of patients with adenoacanthoma and mixed endometrial carcinoma].
    Kazanowska W; Musiatowicz B; Filipowska D; Kurłowicz-Sidun B; Morelowska-Topczewska B
    Probl Med Wieku Rozwoj; 1981; 10():195-200. PubMed ID: 7349394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.
    Duk JM; De Bruijn HW; Groenier KH; Fleuren GJ; Aalders JG
    Cancer; 1990 Apr; 65(8):1830-7. PubMed ID: 2317761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.